Scholars@Duke

Is it time to reconsider combination lipid therapy in high-risk diabetic patients?

Publication ,  Journal Article
Blood, AJ; Krasuski, RA
Published in: Curr Opin Lipidol
June 2016
Published version (DOI) Open Access Copy (Duke) Link to item

Duke Scholars

Richard Andrew Krasuski
Author Richard Andrew Krasuski Medicine, Cardiology

Published In

Curr Opin Lipidol

DOI

10.1097/MOL.0000000000000306

EISSN

1473-6535

Publication Date

June 2016

Volume

27

Issue

3

Start / End Page

310 / 311

Location

England

Related Subject Headings

  • Lipid Metabolism
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Diabetes Complications
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Blood, A. J., & Krasuski, R. A. (2016). Is it time to reconsider combination lipid therapy in high-risk diabetic patients? Curr Opin Lipidol, 27(3), 310–311. https://doi.org/10.1097/MOL.0000000000000306
Blood, Alexander J., and Richard A. Krasuski. “Is it time to reconsider combination lipid therapy in high-risk diabetic patients?” Curr Opin Lipidol 27, no. 3 (June 2016): 310–11. https://doi.org/10.1097/MOL.0000000000000306.
Blood AJ, Krasuski RA. Is it time to reconsider combination lipid therapy in high-risk diabetic patients? Curr Opin Lipidol. 2016 Jun;27(3):310–1.
Blood, Alexander J., and Richard A. Krasuski. “Is it time to reconsider combination lipid therapy in high-risk diabetic patients?” Curr Opin Lipidol, vol. 27, no. 3, June 2016, pp. 310–11. Pubmed, doi:10.1097/MOL.0000000000000306.
Blood AJ, Krasuski RA. Is it time to reconsider combination lipid therapy in high-risk diabetic patients? Curr Opin Lipidol. 2016 Jun;27(3):310–311.

Published In

Curr Opin Lipidol

DOI

10.1097/MOL.0000000000000306

EISSN

1473-6535

Publication Date

June 2016

Volume

27

Issue

3

Start / End Page

310 / 311

Location

England

Related Subject Headings

  • Lipid Metabolism
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Diabetes Complications
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology